Thermo Fisher Scientific's Oncomine Dx Target Test for Non-Small Cell Lung Cancer Receives Coverage from First Regional Health Plan
Press release for the availability of coverage regarding a comprehensive, multi-biomarker test by Regence BlueCross/BlueShield plan members in Oregon, Idaho, Utah, and Washington.
Wrote entire eBook
Researched and wrote a press release unveiling a new cell culture system.
Thermo Fisher Scientific Customers to Showcase Innovations in Precision Genomics Research for Inherited Disease and Reproductive Health at ASHG
Press release for Thermo Fisher Scientific regarding hosting a lunch seminar that highlights the work of several investigators that is being enabled by new technologies the company is introducing at ASHG to advance precision genomics for research in inherited disease and reproductive health.
Article on marketing analytics and attribution.
Leading Pathologists to Showcase First Case Studies with Oncomine Dx Target Test at Association for Molecular Pathology Annual Meeting
Press release for the first-ever presentation of a case study by a laboratory using the Oncomine Dx Target Test--the first NGS-based companion diagnostic for non-small cell lung cancer (NCSLC)
Blog article on GDPR and updated email marketing regulations
Thermo Fisher Scientific Signs Oncology Companion Diagnostic Development Agreement with Blueprint Medicines
Press release for agreement to expand Oncomine Dx Target Test with RET fusion markers to treat non-small cell lung cancer patients.
Ghostwriting article on gamification in marketing.
Press release for a chemically defined, blood- and plant hydrolysate-free cell culture media for vaccine manufacturing.
Ghostwriting blog piece on protein quality